About Proton Unfold

  • Proton Unofold (苏州质子展开科技有限公司) is a new company working on building artificial intelligence to accelerate biopharmaceutical discovery. We are guided by our mission to deposit all the knowledge and experience in biopharmaceutical research, helping the biopharmaceutical industry march towards a vast sea of stars.

Technical Team

  • Our team is led by Dr. Zhaoping Xiong, cofounder and CEO of Proton Unfold, who is an alumnus of ShanghaiTech University and previously headed the Pangu-Drug foundation model project at Huawei.

  • Our team is primarily composed of fresh graduates from esteemed institutions such as the University of Chinese Academy of Sciences, ShanghaiTech University, East China Normal University, China Pharmaceutical University, Dalian University of Technology, Soochow University and Ritsumeikan University. Collectively we contributed some of the most widely used tools like αExtracor, PatMap, Attentive FP, SurfDock, TransformerCPI and KinomeX. Furthermore, we have pioneered the introduction of innovative tools such as Graph-pKₐ, TG468, KinomeMETA, and PBCNet. We have worked on and led the development of some of the breakthroughs in the field including cheminformation extraction and understanding, molecular pretrained foundation model Pangu-Drug, ADMET property prediction, molecular generation, and molecular docking.

Scientific Board

  • Mingyue Zheng, is a professor at Shanghai Instititute of Materia Medica, Chinease Academy of Sciences, and is a recipient of the National Science Fund for Distinguished Young Scholars. His research interests are in AI approaches for rational drug design and discovery.

  • Xiaojie Lu, a Principal Investigator at the Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, specializes in chemical synthesis, particularly DNA encoded libraries, and drug discovery. Prior to his transition into academia, he gained several years of industry experience at GlaxoSmithKline, working on drug discovery in Boston.

Partnerships

  • We partner closely with Shanghai Institute of Materia Medica, ShanghaiTech University and Huawei.

Contact

0%